Home > Careers


Director/Associate Director – Medical Research (FullTime) Apply for this Job

Development and implementation of the 3b/4 clinical trials program. The primary goal of this program will be to maximize the value of Macugen at and beyond commercial launch.

Summary

  • Ensure overall Medical Research goals are aligned with Regulatory and Commercial strategic goals.
  • Develop, implement, and facilitate a review committee for grant proposals from clinical/pre-clinical investigators, and represent Medical Research on the committee.
  • Oversee the progress of all funded grant studies, as summarized in regularly scheduled team meetings, and communicate directly with each investigator from initial contact to publication.
  • Participate in the promotional material review committee and ensure that new data are included appropriately.
  • Participate in Advisory Panels and Consultants Forums.
  • Work with Marketing on projects related to the launch of Macugen.
  • Write clinical protocols, and partner with data management to design appropriate CRFs for 3b/4 program.
  • Design SOPs for implementation of clinical trials, data collection systems and generation of final reports.
  • Negotiate research, confidentiality, and publications agreements.
  • Prepare and manage clinical budgets.
  • Support and liaise with clinical investigators and clinical research staff.
  • Support and liaise with Clinical Development, Commercial, Medical Science Liaisons, and Legal teams.

Qualifications

  • 5 - 10 years of pharmaceutical trials experience.
  • Master’s degree or higher required. Scientific and/or health care background strongly preferred.
  • Highly motivated and independent.
  • Strong leadership and interpersonal skills.
  • Excellent written and verbal communication skills.
  • Clinical Trials budgeting and contract negotiation experience.
  • Ophthalmology and phase 3b/4 experience helpful.


We disclaim any obligation to update the above information, which was last modified on March 22, 2004. Please refer to the Investor Relations – SEC Filings and – Press Releases sections of our web site for more expansive and current information about our company.

© copyrights 2004.
    Eyetech Pharmaceuticals.
 Update Notice | Privacy Policy | Usage Terms